PubMed

Identification of tight junction modulating lipids.

Chen-Quay SC, Eiting KT, Li AW, Lamharzi N, Quay SC.

J Pharm Sci. 2009 Feb;98(2):606-19.PMID: 18563833 [PubMed - indexed for MEDLINE]Related articles

Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL.

Lamharzi N, Renard CB, Kramer F, Pennathur S, Heinecke JW, Chait A, Bornfeldt KE.

Diabetes. 2004 Dec;53(12):3217-25.PMID: 15561953 [PubMed - indexed for MEDLINE]Related articlesFree article

Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions.

Renard CB, Kramer F, Johansson F, Lamharzi N, Tannock LR, von Herrath MG, Chait A, Bornfeldt KE.

J Clin Invest. 2004 Sep;114(5):659-68.PMID: 15343384 [PubMed - indexed for MEDLINE]Related articlesFree article

Polymorphic markers in the 5alpha-reductase type II gene and the incidence of prostate cancer.

Lamharzi N, Johnson MM, Goodman G, Etzioni R, Weiss NS, Dightman DA, Barnett M, DiTommaso D, Chen C.

Int J Cancer. 2003 Jul 1;105(4):480-3.PMID: 12712437 [PubMed - indexed for MEDLINE]Related articles

Androgen receptor polymorphisms and the incidence of prostate cancer.

Chen C, Lamharzi N, Weiss NS, Etzioni R, Dightman DA, Barnett M, DiTommaso D, Goodman G.

Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1033-40.PMID: 12376504 [PubMed - indexed for MEDLINE]Related articlesFree article

Cytotoxic analogs of luteinizing hormone-releasing hormone bind with high affinity to human breast cancers.

Halmos G, Nagy A, Lamharzi N, Schally AV.

Cancer Lett. 1999 Mar 1;136(2):129-36.PMID: 10355741 [PubMed - indexed for MEDLINE]Related articles

Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice.

Miyazaki M, Schally AV, Nagy A, Lamharzi N, Halmos G, Szepeshazi K, Armatis P.

Am J Obstet Gynecol. 1999 May;180(5):1095-103.PMID: 10329861 [PubMed - indexed for MEDLINE]Related articles

Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of IGF-II in tumors.

Lamharzi N, Schally AV, Koppán M.

Regul Pept. 1998 Oct 16;77(1-3):185-92.PMID: 9809814 [PubMed - indexed for MEDLINE]Related articles

Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma.

Koppán M, Halmos G, Arencibia JM, Lamharzi N, Schally AV.

Cancer. 1998 Oct 1;83(7):1335-43.PMID: 9762934 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095.

Miyazaki M, Lamharzi N, Schally AV, Halmos G, Szepeshazi K, Groot K, Cai RZ.

Eur J Cancer. 1998 Apr;34(5):710-7.PMID: 9713279 [PubMed - indexed for MEDLINE]Related articles

Decrease in the level and mRNA expression of LH-RH and EGF receptors after treatment with LH-RH antagonist cetrorelix in DU-145 prostate tumor xenografts in nude mice.

Lamharzi N, Halmos G, Jungwirth A, Schally AV.

Int J Oncol. 1998 Sep;13(3):429-35.PMID: 9683774 [PubMed - indexed for MEDLINE]Related articles

Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors.

Lamharzi N, Schally AV, Koppán M, Groot K.

Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8864-8.PMID: 9671770 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of mRNA for luteinizing hormone-releasing hormone receptors and epidermal growth factor receptors in human cancer cell lines.

Lamharzi N, Halmos G, Armatis P, Schally AV.

Int J Oncol. 1998 Mar;12(3):671-5.PMID: 9472110 [PubMed - indexed for MEDLINE]Related articles

Growth inhibition of human ovarian cancers by cytotoxic analogues of luteinizing hormone-releasing hormone.

Miyazaki M, Nagy A, Schally AV, Lamharzi N, Halmos G, Szepeshazi K, Groot K, Armatis P.

J Natl Cancer Inst. 1997 Dec 3;89(23):1803-9.PMID: 9392622 [PubMed - indexed for MEDLINE]Related articlesFree article

A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers.

Szepeshazi K, Schally AV, Halmos G, Lamharzi N, Groot K, Horvath JE.

Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10913-8.PMID: 9380734 [PubMed - indexed for MEDLINE]Related articlesFree article

Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats.

Pinski J, Lamharzi N, Halmos G, Groot K, Jungwirth A, Vadillo-Buenfil M, Kakar SS, Schally AV.

Endocrinology. 1996 Aug;137(8):3430-6.PMID: 8754771 [PubMed - indexed for MEDLINE]Related articles